Psikiyatrik Bozuklukların Tedavisinde Doğru Beslenme
Özet
Dengeli beslenmenin ruh sağlığı ve psikiyatrik bozuklukların tedavisi üzerindeki kritik rolünü inceleyen bu metin; besin ögeleri, bağırsak mikrobiyotası ve ilaç-gıda etkileşimleri arasındaki ilişkileri kapsamlı bir şekilde ele almaktadır. Akdeniz tipi beslenmenin depresyon riskini azalttığı, yüksek kalorili Batı tarzı beslenmenin ise kognitif fonksiyonları bozduğu belirtilmektedir. B ve D vitaminleri, omega-3 yağ asitleri ile antioksidanlar nöronal fonksiyonları destekleyerek psikiyatrik semptomları iyileştirirken, çinko, magnezyum ve karbonhidrat dengesi nörotransmitter sentezi için hayati önem taşır. Gastrointestinal ve santral sinir sistemi arasındaki çift yönlü iletişimi sağlayan beyin-bağırsak ekseni, mikrobiyotadaki disbiyozis süreciyle doğrudan ruh halini ve davranışları etkilemekte; probiyotik mikroorganizmalar ise anksiyete ve depresyon patofizyolojisinde rol oynayan GABA ve serotonin gibi nörotransmitterlerin üretimine katkıda bulunmaktadır. Ayrıca, besin moleküllerinin enzimlerle etkileşime girerek ilaç farmakokinetiğini değiştirebildiği; antipsikotik, antidepresan, duygudurum düzenleyici ve benzodiazepin grubu ilaçların kilo artışı, kabızlık, vitamin-mineral eksiklikleri ve hipertansif kriz gibi yan etkilere veya etkinlik kayıplarına yol açabileceği vurgulanmaktadır. Sonuç olarak, psikiyatrik hastalıkların yönetiminde beslenme alışkanlıklarının detaylı takibi ve multidisipliner bir yaklaşım tedavinin başarısı için elzemdir.
This text, which examines the critical role of balanced nutrition on mental health and the treatment of psychiatric disorders, comprehensively addresses the relationships between nutrients, gut microbiota, and drug-food interactions. It is stated that a Mediterranean-style diet reduces the risk of depression, whereas a high-calorie Western diet impairs cognitive functions. While B and D vitamins, omega-3 fatty acids, and antioxidants support neuronal functions and improve psychiatric symptoms, the balance of zinc, magnesium, and carbohydrates is vital for neurotransmitter synthesis. The gut-brain axis, which provides bidirectional communication between the gastrointestinal and central nervous systems, directly affects mood and behaviors through the dysbiosis process in the microbiota, and probiotic microorganisms contribute to the production of neurotransmitters such as GABA and serotonin, which play a role in the pathophysiology of anxiety and depression. Furthermore, it is emphasized that nutrient molecules can interact with enzymes to alter drug pharmacokinetics, and that antipsychotic, antidepressant, mood stabilizer, and benzodiazepine group drugs may lead to side effects or loss of efficacy such as weight gain, constipation, vitamin-mineral deficiencies, and hypertensive crises. Consequently, detailed monitoring of nutritional habits and a multidisciplinary approach in the management of psychiatric diseases are essential for the success of the treatment.
Referanslar
Jacka FN, O’Neil A, Opie R, et al. A randomised controlled trial of dietary improvement for adults with major depression (the ‘SMILES’ trial). BMC Med. 2017;15:23.
Noble EE, Hsu TM, Kanoski SE. Gut to brain dysbiosis: mechanisms linking western diet consumption, the microbiome, and cognitive impairment. Front BehavNeurosci 2017;11:9. 10.3389/fnbeh.2017.00009
Firth, J.,Gangwisch, J. E., Borisini, A., Wootton, R. E., &Mayer, E. A. (2020). Foodandmood: how do diet and nutrition affect mental wellbeing?. BMJ (Clinicalresearch ed.), 369, m2382. https://doi.org/10.1136/bmj.m2382
Lim SY, Kim EJ, Kim A, Lee HJ, Choi HJ, YangSJ. Nutritional factors affecting mental health.ClinicalNutritionResearch. 2016;5(3):143-52
Kris-Etherton PM, Petersen KS, Hibbeln JR, Hurley D, Kolick V, Peoples S, Rodriguez N, Woodward-Lopez G. Nutrition and behavioral health disorders: depression and anxiety. NutrRev. 2021 Feb 11;79(3):247-260. doi: 10.1093/nutrit/nuaa025
Mitchell, E. S.,Conus, N., & Kaput, J. (2014). B vitamin polymorphisms and behavior: evidence of associations with neurodevelopment, depression, schizophrenia, bipolar disorder and cognitive decline. Neuroscience and biobehavioral reviews, 47, 307–320. https://doi.org/10.1016/j.neubiorev.2014.08.006
Jin, X.,Cheng, Z., Yu, X., Tao, Q., Huang, R., &Wang, S. (2022). Continuous supplementation of folic acid in pregnancy and the risk of perinatal depression-A meta-analysis. Journal of affective disorders, 302, 258–272. https://doi.org/10.1016/j.jad.2022.01.080
Schneider B, Weber B, Frensch A, Stein J, Fritz J. Vitamin D in schizophrenia, majör depression and alcoholism. J NeuralTransm. 2000;107:839-42
Morello, M.,Landel, V., Lacassagne, E., Baranger, K., Annweiler, C., Féron, F., & Millet, P. (2018). Vitamin D Improves Neurogenesis and Cognition in a Mouse Model of Alzheimer's Disease. Molecularneurobiology, 55(8), 6463–6479. https://doi.org/10.1007/s12035-017-0839-1
Hoang MT, Defina LF, Willis BL. Association between low serum 25-hydroxyvitamin D and depression in a large sample of healthy adults: the Cooper Center longitudinal study. Mayo Clin Proc 2011;86:1050–5.
Demirkol, M. E., Tamam, L., Çakmak, S., & Yeşiloğlu, C. (2019). Şizofreni tanılı hastalarda metaboliksendrom ve D vitamini düzeyleri ilişkisi. Cukurova Medical Journal, 44(3), 1110-1117.
Grosso G, Pajak A, Marventano S, Castellano S, Galvano F, Bucolo C, et al. Role of omega-3 fatty acids in the treatment of depressive disorders: A comprehensive meta-analysis of randomized clinical trials. PLOS ONE 2014; 9: e96905
Lakhan SE, Vieira KF. Nutritional therapies for mental disorders. Nutrition Journal 2008; 7:2
Hennebelle M, Champeil-Potokar G, Lavialle M, Vancassel S, Denis I. Omega-3 polyunsaturated fatty acids and chronic stress induced modulations of glutamatergic neurotransmission in the hippocampus. Nutrition Review 2014; 72: 99–112
Kim, S. H., Park, Y. M., Choi, B. Y., Kim, M. K., Roh, S., Kim, K., & Yang, Y. J. (2018). Associations of serum levels of vitamins A, C, and E with the risk of cognitive impairment among elderly Koreans. Nutrition research and practice, 12(2), 160–165. https://doi.org/10.4162/nrp.2018.12.2.160
Vashum KP, McEvoy M, Milton AH, McElduff P, Hure A, Byles J, Attia J. Dietary zinc is associated with a lower incidence of depression: findings from two Australian cohorts. J Affect Disord. 2014 Sep;166:249-57. doi: 10.1016/j.jad.2014.05.016. Epub 2014 May 23. PMID: 25012438.
Portbury SD, Adlard PA. Zinc Signal in Brain Diseases. Int J Mol Sci. 2017 Nov 23;18(12):2506. doi: 10.3390/ijms18122506. PMID: 29168792; PMCID: PMC5751109.
Özenoğlu, A. (2018). Duygu durumu, besin ve beslenme ilişkisi. Acıbadem Üniversitesi Sağlık Bilimleri Dergisi, (4), 357-365
Zhang, X.; Zhang, G.; Zhang, H.; Karin, M.; Bai, H.; Cai, D. Hypothalamic IKK_/NF-kB and ER stress Link Overnutrition. Cell 2009, 135, 61–73.
Fu, Y.; Kaneko, K.; Lin, H.-Y.; Mo, Q.; Xu, Y.; Suganami, T.; Ravn, P.; Fukuda, M. Gut Hormone GIP Induces Inflammation and Insulin Resistance in the Hypothalamus. Endocrinology 2020, 161
Özen Ş, Haspolat K. D Vitamini, Kalsiyum, Kemik Metabolizması ve Psikiyatrik Bozukluklar. Klinik Psikiyatri 2003; 6:102-113.
Hatun Ş. Çocuk Hakları Sözleşmesinin 13. Yılında Yoksulluk ve Çocuklar Üzerine Etkileri. Türk Tabipleri Birliği Merkez Konseyi:2002.
Carlessi, A. S.,Borba, L. A., Zugno, A. I., Quevedo, J., &Réus, G. Z. (2021). Gut microbiota-brainaxis in depression: The role of neuroinflammation. TheEuropeanjournal of neuroscience, 53(1), 222–235. https://doi.org/10.1111/ejn.14631
Laparra, J. M.,&Sanz, Y. (2010). Interactions of gut microbiota with functional food components and nutraceuticals. Pharmacologicalresearch, 61(3), 219–225. https://doi.org/10.1016/j.phrs.2009.11.001
Bercik, P.,Denou, E., Collins, J., Jackson, W., Lu, J., Jury, J., Collins, S. M. (2011b). The intestinal microbiota affect central levels of brain-derived neurotropic factor and behavior in mice. Gastroenterology, 141, 599–609. https://doi.org/10.1053/j.gastro.2011.04.052
Generoso, J. S.,Giridharan, V. V., Lee, J., Macedo, D., &Barichello, T. (2021). The role of the microbiota-gut-brain axis in neuropsychiatric disorders. Revistabrasileira de psiquiatria (Sao Paulo, Brazil : 1999), 43(3), 293–305. https://doi.org/10.1590/1516-4446-2020-0987
Mitrea, L., Nemeş, S. A., Szabo, K., Teleky, B. E., &Vodnar, D. C. (2022). Guts Imbalance Imbalances the Brain: A Review of Gut Microbiota Association With Neurological and Psychiatric Disorders. Frontiers in medicine, 9, 813204. https://doi.org/10.3389/fmed.2022.813204
Fond, G. B.,Lagier, J. C., Honore, S., Lancon, C., Korchia, T., Sunhary De Verville, P. L., Llorca, P. M., Auquier, P., Guedj, E., & Boyer, L. (2020). Microbiota-Orientated Treatments for Major Depression and Schizophrenia. Nutrients, 12(4), 1024. https://doi.org/10.3390/nu12041024
Gezmen-Karadağ, M., Çelik, E., Kadayifçi, F. Z., Yeşildemir, Ö., Öztürk, Y. E., &Ağagündüz, D. (2018). Role of food drug interactions in neurological and psychologicaldiseases. Actaneuro biologiae experimentalis, 78(3), 187–197.
Cheng, L.-H.; Liu, Y.-W.;Wu, C.-C.;Wang, S.; Tsai, Y.-C. Psychobiotics in mental health, neurodegenerative and neurodevelopmental disorders. J. Food Drug Anal. 2019, 27, 632–648
Schousboe, A.,&Waagepetersen, H. S. (2007). GABA: Homeostatic and pharmacological aspects. Progress in Brain Research, 160, 9–19. https://doi.org/10.1016/s0079-6123(06)60002-2
Holzer, P.,&Farzi, A. (2014). Neuropeptides and the microbiota gut brain axis. Advances in Experimental Medicine and Biology, 817, 195–219. https://doi.org/10.1007/978-1-4939-0897-4_9
Kim, N., Yun, M., On, Y. J., &Choi, H. J. (2018). Mind-altering with the gut: Modulation of the gut-brain axis with probiotics.Journal of Microbiology, 56, 172–182. https://doi.org/10.1007/s12275-018-8032-4
Vallianou N.,Stratigou T., Christodoulatos G.S., Tsigalou C., Dalamaga M. Probiotics, Prebiotics, Synbiotics, Postbiotics, and Obesity: Current Evidence, Controversies, and Perspectives. Curr. Obes. Rep. 2020;9:179–192. doi: 10.1007/s13679-020-00379-w
Bruce-Keller, A. J., Salbaum, J. M., Luo, M., Blanchard IV, E., Taylor, C. M., Welsh, D. A., & Berthoud, H. R. (2015). Obese-type gut microbiota induce neurobehavioral changes in the absence of obesity. Biological psychiatry, 77(7), 607-615.
Briguglio M, Hrelia S, Malaguti M, Serpe L, Canaparo R, Dell'Osso B, Galentino R, De Michele S, Dina CZ, Porta M, Banfi G. Food Bioactive Compounds and Their Interference in Drug Pharmacokinetic/Pharmacodynamic Profiles. Pharmaceutics. 2018 Dec 14;10(4):277. doi: 10.3390/pharmaceutics10040277. PMID: 30558213; PMCID: PMC6321138.
Aksoy M (2016) Food and Drug Interaction (in Turkish). İstanbul Tıp Kitape vi, İstanbul, Turkey
Elmacıoğlu F (2007) Food and drug interaction (in Turkish). Turkiye Klinikleri Journal of Internal Medical Sciences 3: 108–120.
Pronsky Z, Crowe J (2012) Krause’s Food and Nutrition Care Process. Mahan L, Escott Stump S, Raymond J, editors. USA: Elsevier; 209–228 p.
Dysken MW, Cumming RJ, Channon RA, Davis JM (1979) Drug interaction between ascorbic acid and fluphenazine. JAMA 241: 2008
Reekie J, Hosking S, Prakash C, Kao KT, Juonala M, Sabin M (2015) The effect of antidepressants and antipsychotics on weight gain in children and adolescents. Obes Rev 16: 566–580
Ismail MYM (2009) Drug food interactions and role of pharmacist. Asian J Pharm Clin Res 2: 1–10
Flockhart DA. Dietary restrictions and drug interactions with monoamine oxidase inhibitors: an update. J Clin Psychiatry. 2012;73 Suppl 1:17-24. doi: 10.4088/JCP.11096su1c.03. PMID: 22951238.
Fukuda M, Kawabe M, Takehara M, Iwano S, Kuwabara K, Kikuchi C, Wakamoto H, Morimoto T, Suzuki Y, Ishii E (2015) Carnitine deficien cy: Risk factors and incidence in children with epilepsy. Brain Dev 37: 790–796.
Marahatta A, Bhandary B, Jeong SK, Kim HR, Chae HJ (2014) Soybean greatly reduces valproic acid plasma concentrations: A food–drug in teraction study. Sci Rep 4: 436
Gray, G. E., & Gray, L. K. (1989). Nutritional aspects of psychiatric disorders. Journal of the American Dietetic Association, 89(10), 1492–1498.
Özaydın N, Şensoy F, Özaydın N. Yaşlılarda besin ilaç etkileşimi. Sted 2016;25(3):125-130
